Cargando…
Hydroxychloroquine may reduce risk of Pneumocystis pneumonia in lupus patients: a Nationwide, population-based case-control study
BACKGROUND: Pneumocystis pneumonia (PCP) is increasingly being diagnosed in patients with systemic lupus erythematosus (SLE), and hydroxychloroquine (HCQ) has been found to possess antifungal activities. We hence aimed to investigate the association between HCQ and PCP risk among patients with SLE....
Autores principales: | Yeo, Kai-Jieh, Chen, Hsin-Hua, Chen, Yi-Ming, Lin, Ching-Heng, Chen, Der-Yuan, Lai, Chih-Ming, Chao, Wen-Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7011312/ https://www.ncbi.nlm.nih.gov/pubmed/32041539 http://dx.doi.org/10.1186/s12879-020-4826-1 |
Ejemplares similares
-
A DRY COUGH CONUNDRUM: A RARE CASE OF PNEUMOCYSTIS JIROVECII PNEUMONIA IN SYSTEMIC LUPUS ERYTHEMATOUS PATIENT ON HYDROXYCHLOROQUINE
por: Verghese, Elizabeth, et al.
Publicado: (2020) -
Pneumocystis jirovecii pneumonia in autoimmune rheumatic diseases: a nationwide population-based study
por: Hsu, Hui-Ching, et al.
Publicado: (2021) -
A retrospective study of patients with systemic lupus erythematosus combined with Pneumocystis jiroveci pneumonia treated with caspofungin and trimethoprim/sulfamethoxazole
por: Wang, Zhi-Guo, et al.
Publicado: (2019) -
Risk of herpes zoster in patients with systemic lupus erythematosus: a three-year follow-up study using a nationwide population-based cohort
por: Chen, Hsin-Hua, et al.
Publicado: (2011) -
Clinical Usefulness of HRCT in Assessing the Severity of Pneumocystis jirovecii Pneumonia: A Cross-sectional Study
por: Chou, Chung-Wei, et al.
Publicado: (2015)